Coiled Therapeutics plc

COIL · AIM · Health Care · mcap £32m · 6.1p

Beta Briefing, track record and bull & bear case are not ready for Coiled Therapeutics plc yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 34 companies are already wired into a briefing: browse them.

Trevor Reginald 25 Nov · 1 notice

2.4% → 6.5%

share price at the notices 17.8p · now 6.1p 25 Nov 2025

Directors

purchase Roquefort Therapeutics plc announced that Interim Managing Director Dr. Darrin Disley purchased 5,000,000 ordinary shares at an average price of 1.70 pence per share, totaling £85,000. This transaction increases his tota 24 Nov 2025

other Coiled Therapeutics plc has appointed Dr. Andrew Dean as a Non-Executive Director, bringing extensive oncology expertise to the board. Dr. Dean, who currently consults for GenesisCare and heads Oncology at St John of God 7 May 2026

award Coiled Therapeutics plc has appointed Craig A. Tooman as an Independent Non-Executive Director, effective June 25, 2026, bringing extensive experience in the pharmaceutical and biotechnology sectors, including raising ne 24 Jun 2026

purchase Stephen West, a Non-Executive Director of Coiled Therapeutics plc, has purchased 531,743 ordinary shares for a total consideration of £40,016.77, with an average price of 7.52 pence per share. This transaction increases 28 Sep 2026

Company filings. Not investment advice.